Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps

Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced Chronic Kidney Disease

(2023) Yasuyuki Ushiogi et al.   Clinical Journal of the American Society of Nephrology

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

(2022) Fernando Gomez‐Peralta et al.   DIABETES OBESITY & METABOLISM

Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study

(2022) Eun Yeong Ha et al.   Frontiers in Endocrinology

Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes

(2022) James Ling et al.   Kidney International Reports

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

(2022) Alberto Maran et al.   DIABETES CARE

Assessment of the Glucose Management Indicator Using Different Sampling Durations

(2022) Ryan Bailey et al.   Diabetes Technology & Therapeutics

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2022) Melanie J. Davies et al.   DIABETOLOGIA

11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023

(2022) Nuha A. ElSayed et al.   DIABETES CARE

Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes

(2021) Elena Toschi et al.   DIABETES CARE

Effects of the hemoglobin glycation index on hyperglycemia diagnosis: Results from the REACTION study

(2021) Lu Lin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease

(2021) Yutaro Ogawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease

(2020) Rodolfo J Galindo et al.   ENDOCRINE REVIEWS

Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease

(2020) Leila R. Zelnick et al.   DIABETES CARE

A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison

(2020) Ananta Addala et al.   DIABETES CARE

HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis

(2020) Jordan E. Perlman et al.   Diabetes Technology & Therapeutics

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

(2015) Timothy Bailey et al.   Diabetes Technology & Therapeutics

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

(2015) Kunihiro Matsushita et al.   Lancet Diabetes & Endocrinology

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring

(2011) FREDERIEK E VOS et al.   NEPHROLOGY

Translating the A1C Assay Into Estimated Average Glucose Values

(2008) D. M. Nathan et al.   DIABETES CARE

Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005

(2008) Erin McLean et al.   PUBLIC HEALTH NUTRITION